You are here
Annals of Internal Medicine and ACP Announce Recipients of Junior Investigator Recognition Awards
Philadelphia, April 10, 2019 – Annals of Internal Medicine and the American College of Physicians (ACP) will honor Muhammad Hammadah, MD; Jeong Hwan Kim, MD; and Sachin J Shah, MD, MPH, with Junior Investigator Recognition Awards at Internal Medicine Meeting 2019, ACP’s annual scientific meeting taking place April 11-13 in Philadelphia.
Annals’ Junior Investigator Recognition Awards are presented annually to early career physicians. Annals and ACP award the most outstanding article by a first author who is in an internal medicine residency program or a general medicine or internal medicine subspecialty fellowship program. An award is also given for the most outstanding article with a first author who is within three years of completing his or her training in internal medicine or one of its subspecialties.
Muhammad Hammadah, MD is a cardiology fellow in the clinical investigator track at Emory University in Atlanta, GA. Dr. Hammadah received his medical degree from the University of Aleppo, Syria and completed his residency at the Cleveland Clinic. He is an active American College of Cardiology fellow in training and planning to pursue and academic career in interventional cardiology. He is being recognized for an article he authors, “Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study” which was published in the November, 6, 2018 issue.
Jeong Hwan Kim, MD is also a cardiology fellow in the clinical investigator track at Emory University in Atlanta, GA, as well as the American Heart Association Strategically Focused Research Network (Disparities) Post-doctoral Fellow for the Morehouse-Emory Cardiovascular Center for Health Equity (MECA). Dr. Kim received his medical degree from the University of Chicago Pritzker School of Medicine. He is also being recognized for an article he authors, “Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study” which was published in the November, 6, 2018 issue.
Sachin J. Shah, MD, MPH is an assistant professor in the Division of Hospital Medicine at the University of California, San Francisco. He completed his fellowship in general medicine at Massachusetts General Hospital and earned his MPH from Harvard TH Chan School of Public Health. Dr. Shah specializes in health outcomes and population health research with the goal of improving the health of older, vulnerable adults. He is being recognized for an article he authors, “Effect of Variation in Published Stroke Rates on the Net Clinical Benefit of Anticoagulation for Atrial Fibrillation” which was published in the September, 25, 2018 issue.
Winners are selected based on the article’s novelty, methodological rigor, clarity of presentation, and potential to influence practice, policy or future research. Judges include Annals’ editors and representatives from Annals’ Editorial Board and the American College of Physicians’ Education and Publication Committee.
About Annals of Internal Medicine
Annals of Internal Medicine is one of the most widely cited and influential medical journals in the world, with an impact factor of 19.384 – the highest of any specialty journal in its category. Annals’ mission is to promote excellence in medicine, enable physicians and other health care professionals to be well informed members of the medical community and society, advance standards in the conduct and reporting of medical research, and contribute to improving the health of people worldwide. Established in 1927, Annals is the flagship journal of the American College of Physicians (ACP).
About the American College of Physicians
The American College of Physicians is the largest medical specialty organization in the United States with members in more than 145 countries worldwide. ACP membership includes 154,000 internal medicine physicians (internists), related subspecialists, and medical students. Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise Twitter and Facebook, and Instagram.